Cite
APA Citation
Mohr, I., Bourhis, H., Woimant, F., Obadia, M. A., Morgil, M., Morvan, E., Merle, U., Denk, G., Poujois, A., & Weiss, K. H. (2023). experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HCl. Journal of gastroenterology and hepatology, 38(2), 219–224. http://access.bl.uk/ark:/81055/vdc_100177573469.0x000049